author-photo

G Wright

Sarah Cannon Research Institute

1

Papers

1

Citations

Citation Trend

Filter By

Papers (1) Sort By

Journal Conference Others

Abstract GS4-01: Results from CONTESSA: A phase 3 study of tesetaxel plus a reduced dose of capecitabine versus capecitabine alone in patients with HER2-, hormone receptor + (HR+) metastatic breast cancer (MBC) who have previously received a taxane

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)